Ritholtz Wealth Management Dr Reddys Laboratories LTD Transaction History

Ritholtz Wealth Management

  • $4.45 Billion
  • Q2 2025

A detailed history of Ritholtz Wealth Management transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ritholtz Wealth Management holds 32,295 shares of RDY stock, worth $475,705. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,295
Previous 43,301 25.42%
Holding current value
$475,705
Previous $571,000 15.06%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
SELL
$12.36 - $16.17 $136,034 - $177,967
-11,006 Reduced 25.42%
32,295 $485,000
Q1 2025

Apr 16, 2025
SELL
$12.53 - $15.81 $467,293 - $589,618
-37,294 Reduced 46.27%
43,301 $571,000
Q4 2024

Jan 14, 2025
BUY
$13.99 - $79.75 $883,888 - $5.04 Million
63,180 Added 362.79%
80,595 $1.27 Million
Q3 2024

Oct 10, 2024
BUY
$75.41 - $84.21 $118,242 - $132,041
1,568 Added 9.89%
17,415 $1.38 Million
Q2 2024

Jul 31, 2024
BUY
$68.26 - $76.19 $3,208 - $3,580
47 Added 0.3%
15,847 $1.21 Million
Q1 2024

Apr 24, 2024
BUY
$67.36 - $77.59 $136,269 - $156,964
2,023 Added 14.68%
15,800 $1.16 Million
Q4 2023

Jan 18, 2024
BUY
$64.27 - $69.9 $210,612 - $229,062
3,277 Added 31.21%
13,777 $958,000
Q3 2023

Oct 13, 2023
BUY
$61.9 - $72.77 $216,835 - $254,913
3,503 Added 50.06%
10,500 $702,000
Q2 2023

Jul 14, 2023
BUY
$53.34 - $63.11 $53,980 - $63,867
1,012 Added 16.91%
6,997 $441,000
Q1 2023

Apr 19, 2023
BUY
$51.63 - $56.93 $59,684 - $65,811
1,156 Added 23.94%
5,985 $340,000
Q4 2022

Jan 18, 2023
BUY
$51.15 - $57.45 $37,953 - $42,627
742 Added 18.16%
4,829 $0
Q3 2022

Oct 18, 2022
SELL
$49.9 - $57.32 $1,397 - $1,604
-28 Reduced 0.68%
4,087 $214,000
Q2 2022

Jul 15, 2022
SELL
$49.62 - $58.13 $36,966 - $43,306
-745 Reduced 15.33%
4,115 $228,000
Q1 2022

Apr 14, 2022
SELL
$48.27 - $65.25 $369,555 - $499,554
-7,656 Reduced 61.17%
4,860 $271,000
Q4 2021

Jan 18, 2022
SELL
$59.5 - $67.25 $147,679 - $166,914
-2,482 Reduced 16.55%
12,516 $819,000
Q3 2021

Oct 14, 2021
SELL
$60.19 - $75.29 $284,518 - $355,895
-4,727 Reduced 23.96%
14,998 $977,000
Q2 2021

Jul 20, 2021
BUY
$62.12 - $74.2 $289,727 - $346,068
4,664 Added 30.97%
19,725 $1.45 Million
Q1 2021

May 12, 2021
BUY
$57.98 - $73.08 $40,875 - $51,521
705 Added 4.91%
15,061 $925,000
Q4 2020

Jan 19, 2021
BUY
$62.61 - $71.29 $81,142 - $92,391
1,296 Added 9.92%
14,356 $1.02 Million
Q3 2020

Oct 23, 2020
BUY
$51.39 - $72.41 $159,925 - $225,339
3,112 Added 31.28%
13,060 $908,000
Q2 2020

Jul 15, 2020
BUY
$39.55 - $54.65 $393,443 - $543,658
9,948 New
9,948 $527,000

Others Institutions Holding RDY

# of Institutions
260
Shares Held
93.2M
Call Options Held
0
Put Options Held
0
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.45B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Ritholtz Wealth Management Portfolio

Follow Ritholtz Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email